John Fieldly
Also at Celsius Holdings Inc
About
John Fieldly is a seasoned executive with deep financial expertise and a background as a Certified Public Accountant in Florida, which has shaped his successful career journey.
He built his foundation by earning a Bachelor of Science degree in Accounting from the University of South Florida, and he later honed his skills through leadership roles in retail financial management and at companies like Eckerd and Lebhar-Friedman.
At CELH, his strategic leadership has been instrumental in transforming the company, first as Chief Financial Officer from January 2012, then as Interim CEO and CFO during a transitional phase, and ultimately as CEO since April 2018. His guidance has driven significant growth, operational improvements, and key partnerships that have solidified CELH’s market presence.
$CELH Performance Under John Fieldly
Past Roles
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Celsius Holdings, Inc. | Interim Chief Executive Officer and Chief Financial Officer | March 2017 - March 2018 | Held dual role prior to becoming President, CEO, and Chairman |
| Celsius Holdings, Inc. | Chief Financial Officer (CFO) | 2012 - 2017 | Served as CFO before his interim dual role |
| Celsius Holdings, Inc. | Member of the Board of Directors | March 2017 - August 2020* | Served as non-chair board member before being appointed Chairman (inferred from context) |
| Lebhar-Friedman | Leadership Role | N/A | Held a leadership role prior to joining CELH |
| Oragenics, Inc. | Leadership Role | N/A | Held a leadership role prior to joining CELH |
| Eckerd Drugs, Inc. | Leadership Role | N/A | Held a leadership role prior to joining CELH |
Fixed Compensation
| Component Name | Amount | Payment Schedule | Additional Details |
|---|---|---|---|
| Base Salary | $850,000 | Payable in installments (at least monthly) | Subject to periodic review by the Board; consistent with the Company's practice for its other executives |
Performance Compensation
Annual Cash Bonus
| Metric | Details |
|---|---|
| Target Bonus | 100% of base salary: $850,000 |
| Breakdown | 75% tied to financial goals (e.g., revenue, gross profit, adjusted EBITDA) ; 25% tied to organizational & individual performance goals |
| Performance Levels | Threshold: 50% payout at 80% target performance ; Target: 100% payout at 100% performance ; Maximum: 150% payout when performance is 116% or above |
| Evaluation Period | Calendar year 2024; payouts finalized post receipt of audited financial statements |
| Payout Cap | Maximum payout capped at 150% of the target bonus (i.e., up to $1,275,000) |
Annual Equity Awards
| Metric | Details |
|---|---|
| Grant Date | January 1, 2024 |
| Grant Date Target Value | $3,000,000 for the long-term incentive award |
| Award Plan | Issued under the 2015 Stock Incentive Plan (or its successor) |
| Vesting Schedule | Not explicitly detailed for 2024; prior awards (e.g., RSUs) typically vested in equal installments over three years |
| Performance Metrics | Specific performance metrics (e.g., financial targets, TSR) for 2024 are not provided; prior metrics have included such financial and strategic organizational goals |
| Conditions | Subject to Board approval and the plan’s terms; may include double-trigger change-in-control provisions |
Note: Some details such as exact performance metric thresholds for equity awards and grant date fair value/stock price are not disclosed in the documents.